Герпевир® 200 мг таблетки

Država: Kirgizistan

Jezik: ruščina

Source: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Aktivna sestavina:

Ацикловир

Dostopno od:

ПАО "Киевмедпрепарат" (ПАО "Киевмедпрепарат")

Koda artikla:

S01AD03

INN (mednarodno ime):

Acyclovir

Odmerek:

200 мг

Farmacevtska oblika:

таблетки

Enote v paketu:

№20

Tip zastaranja:

по рецепту

Izdeluje:

ПАО "Киевмедпрепарат" (Украина)

Terapevtsko območje:

Противовирусное средство

Povzetek izdelek:

ПЖВЛС: нет

Datum dovoljenje:

2019-03-05

Lastnosti izdelka

yTBEPntAAIO
Aen
o6ecueqeu[s
tl
Mun
Axa
lrHCTpyKuI{tr
IIO
MEAIIUI,IHCKOMy
TIPIIMEHEHI,IIO
JIEKAPCTBEHHOTO
TIPETIAPATA
fEPTIEBI4PA'
(HERPEVIR)
Topronoe
HalrMeHoBaIruc
6r)
I
eprleBrrp-
Mex,(yuapogHoe
HerlareHToBaHHoe
Ha3BaHIre
Aqurronup
""'r1ffi7
Cocras
I
:ra6nerxa
coAepxorr
feircmeyrouqee
Geulecmso'.
aIIIrKnoBlIpa
B
nepecqere
200
r'ar;
B
c
nou
o
zam
e
fl
bHbt
e
G
eul
e c
mG
a
:
KpaxMaJI
xapro
{
elrurtfi
,
noru.qou,
JlerapcrneHHafl
rfopua
Ta6rerrra
Onucasue
Ta6:rerrra
6eloro
prJrr.r
florru4
6eroro
rrBera,
rpyrnofi
$opusr
c
uocrofi
noBepxHocrblo,
c
Qacxofi.
(DapnaxorepareBTuqecKafl
rpyrra
flporunonupycHble
cpe,qcrBa
rnfl
Koq
ATX
J05AB01.
Oapvraro.nourrrecrcue
csoft
crna
@apuarcoduHqtiluKe.
cr4creMHoro
[pI{MeHeHI{s.
Au}rrrosup.
Aqurlonup
flBnrerc,
clrHTerr.rqecKr.rM
aHaJIoroM
[ypl4HoBoro
HyKneo3v[a
c
uuru6uropnofi
aKTlIBHocrtw
in
vivo
u
in
vitro
orHocr.rreJlbHo
Bl{pyca
repueca
geJIoBeKa,
rITo
BKJIIoqaer
BLIpyc
repleca
I
n
II
rr{fra,
Brrpyc
nerprnofi
octlbl
LI
onoscblBa}ouero
repneca,
Bupyc
3nrurefina-
Eappa
v
ur4ToMeraJroBupyc.
B
Kynbrype
KJIeroK
aIILIKJIoBI{p
nposBJlfler
sau6oluuyto
aKTr4BHocrb
nporlrB
Br{pyca
npocroro
reptreca
I
runa
I{
AaJIee,
no
y6unaul4lo
a(TIrBHocrI'I,
rrporr{B
Br.rpyca
[pocroro
repneca
II
runa,
Bl4pyca
nerpruoft
ocIIbI
I4
onoscblBa]oqero
repreca,
Br4pyca
3nureftua-Bappa
u
ql'IroMeranoBl4pyca.
I4uru6uropuaa
aKTr4BHocrb
arlilKnoBHpa
nporLIB
BblllreyrioMf,Hyrblx
BI,IpycoB
flBJUIercfl
BbrcoKoceJrexrunuofi.
@epueur
rr4MHAr{HKr.rHa3a
B
HopMilnbHofi
nerEn$uquponauuofi
KJIerKe
He
Hcnonmyer
arlr,rKnoBr,rp
B
Kaqecrne
cy6crpara,
rro3ToMy
roKcl,IqecKoe
Aeficreue
orHocI'ITeJIbHo
KJI9TOK
OpfaH[3Ma-XO3gI'IHa
f,BirfleTCS
MHHL{Ma!'IIHrIM.
oAUaro
T}IMI',IAI{HKI',IHa3a,
3aKoAlrpoBalnafr,
B
Br{pycax
[pocroro
repreca,
nerpauoft
ocnbl,
ortoqcblBarolqero
repneca
Lr
Brrpycax
3urureftHa-Bappa,
ilpeBparqaer
arIr4KJroBI{p
B
MoHoQocSat
aIII{KJIoBLIpa
-
aHaJIor
pa
Ha
100
%
BelrlecrBo
KaJrbrlrrs
cTeapaT.
HyKneo3rrAa,
KoTopblfi
sareNl
rpeBpaqaeTcfl
[ocJIeAoBaTeJIbHo
n
guSoCQat
u
tpu$Oc$at
C
rroMorrlbro
$epneuton
KleTKI4.
Bcn